Clinical Trials Logo

Wolff-Parkinson-White Syndrome clinical trials

View clinical trials related to Wolff-Parkinson-White Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT06349109 Recruiting - Clinical trials for Wolff-Parkinson-White Syndrome

Physical Activity in Children With Wolff-Parkinson-White Syndrome

Start date: March 1, 2024
Phase:
Study type: Observational

The aim of this study was to investigate the level of physical activity and its determinants in children with WPW.

NCT ID: NCT06260384 Recruiting - Arrythmias Clinical Trials

Wolf-Parkinson-White Syndrome and Asymptomatic Pre-excitation in Africa (a Multicenter WPW African Registry)

Start date: May 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this prospective observational study is to characterize the clinical profile of patients with WPW syndrome and patients with asymptomatic WPW pattern on ECG in different African countries and how these patients are managed across Africa Participants would include many different ethnicities at centers where the number of cardiac patients treated is high. All patients attending outpatient cardiology clinics or referred to Cath Lab for electrophysiological studies who are diagnosed to have a Wolf-Parkinson white pattern on the ECG are either symptomatic or asymptomatic. All patients fulfilling the eligibility criteria will be approached by the research team and asked if they wish to take part in the study. The exclusion criteria will be any participant who does not consent to the study. A baseline cardiovascular history (including hypertension, diabetes, heart failure, coronary artery disease, hyperlipidemia, smoking, valve disease, and arrhythmia) will be recorded. A detailed history will be taken about symptoms, medications and presence of family history of similar cases or sudden cardiac death 12-lead ECG will be recorded to confirm the presence of pre-excitation and determine the localization of the accessory pathway using the modified Aruda algorithm. This will be done by two of the research teams in each center. Then other data from the electrophysiological study and ablation will be filled in by the research team from the data systems of each center.

NCT ID: NCT04361006 Completed - Cardiac Arrhythmias Clinical Trials

Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

A randomized pilot study to evaluate safety and efficacy endpoints for treatment of para-hisian accessory pathways according to two different strategies of lesion formation. These patients will be divided into 2 groups with different strategies of treatment: group 1 treated with radiofrequency (RF) ablation, group 2 with cryotherapy (CRYO). The primary outcome will be the recurrence rate of accessory pathway conduction after one year of follow-up. Secondary endpoints will be immediate success and rate of permanent atrioventricular (AV) block.

NCT ID: NCT04106622 Not yet recruiting - Clinical trials for Wolff-Parkinson-White Syndrome

Accessory Pathway Antegrade Effective Refractory Period Among WPW Patients: the Risk in Relation to the Location

Start date: March 1, 2020
Phase:
Study type: Observational [Patient Registry]

To correlate the antegrade effective refractory period of the accessory pathway with its anatomical location in the heart. To investigate whether the accessory pathway location can predict the high risk nature of the accessory pathway

NCT ID: NCT03301935 Completed - Clinical trials for Wolff-Parkinson-White Syndrome

Risk Assessment in Patients With Symptomatic- and Asymptomatic Preexcitation

RASAP
Start date: December 1, 2016
Phase:
Study type: Observational

Prospective cohort study including 150 patients with pre-excitation on ECG referred to our clinic for risk assessment. There will be equal numbers of symptomatic and asymptomatic patients included in the study. Each patient will perform an exercise stress test on bicycle before an invasive electrophysiological test. The purpose of this study is to compare exercise stress testing on bicycle to an invasive electrophysiological study, regarding risk assessment of patients with pre-excitation. The electrophysiology study is set as reference.

NCT ID: NCT03207373 Terminated - Clinical trials for Sudden Cardiac Death

Stress ECG Test for the Evaluation of the Risk of Sudden Cardiac Death in a Paediatric Cohort With WPW Pattern

Start date: April 13, 2017
Phase: N/A
Study type: Interventional

Patients with preexcitation are at risk for sudden cardiac death. The pathogenesis is a rapid antegrade conduction of atrial fibrillation over the accessory pathway to the ventricle resulting in ventricular fibrillation. Today it is possible to eliminate the conduction over the accessory pathway by catheter intervention (radiofrequency ablation) with a low rate of complications and a high rate of success. In clinical practice it is therefore important to estimate the risk for sudden cardiac death in an individual patient to give an advice to the patient and the parents about the further evaluation and therapeutic strategy. The velocity of the conduction over the accessory pathway can be estimated by analysing the ECG during sinus tachycardia. If the preexcitation disappears at a relatively low heart rate, the risk for sudden death is less than in patients with persisting preexcitation at the maximal heart rate. Compared to the gold standard i.e. measurement of the refractory period of the accessory pathway during invasive electrophysiological study (EPS), the measurements at the stress ECG have been reported to be a relatively poor indicator for an elevated risk which may be explained by a high intraindividual variability of this test. This study is designed to define the clinical relevance of the stress ECG in paediatric patients with preexcitation (compared to the invasive electrophysiological study). First Hypothesis: The results of the 3 stress ECG-tests are reproducible in an individual patient. Null hypothesis: there is no difference between the three measurements of cycle length during stress ECG. Alternate hypothesis: the difference between the three measurements of cycle length is > 10%. Second Hypothesis: There is a close correlation between the results at stress ECG and the results at the invasive electrophysiological Intervention.

NCT ID: NCT00873470 Terminated - Clinical trials for Wolff-Parkinson-White Syndrome

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct

WPW
Start date: February 2009
Phase: N/A
Study type: Interventional

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago. The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome. This study will be realized by esophageal stimulation.

NCT ID: NCT00251121 Completed - Atrial Fibrillation Clinical Trials

Routine Mini-invasive Electrophysiology Study for Patients Feeling Tachycardia, With a Negative Holter ECG

Start date: November 2005
Phase: N/A
Study type: Interventional

Patients complaining of tachycardia but with a negative Holter ECG, are for a limited time period offered a simplified electrophysiological(EP) examination. By a full electrophysiological study(EP study)electrodes are introduced for pacing and sensing i all four heart chambers. Where as by the mini invasive EP study only one electrode is introduced to the right atrium. The simplified procedure represent a smaller risk of complications, requires less resources but should yield the same diagnoses in more than 90% of the cases. The study is a feasibility study to see if the procedure can discover arrythmias in a fairly unselected patient population.